Literature DB >> 9099972

Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre.

D Burke1, C Fordy, S A Earlam, T G Allen-Mersh.   

Abstract

Hepatic arterial cannulation for regional chemotherapy was achieved in 121/134 (90.2%) of colorectal liver metastasis patients. The perioperative mortality (5.8%) was significantly greater (P = 0.004) in patients with > 1000 ml (5/22, 23%) compared with < 1000 ml (2/83, 2.4%) metastasis volume. Colorectal liver metastasis patients should be considered for regional chemotherapy before metastases become extensive.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9099972      PMCID： PMC2222792          DOI： 10.1038/bjc.1997.207

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  17 in total

1.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

Authors:  A E Chang; P D Schneider; P H Sugarbaker; C Simpson; M Culnane; S M Steinberg
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

Review 2.  Fulminant viral hepatitis.

Authors:  P J Jenkins; R Williams
Journal:  Clin Gastroenterol       Date:  1980-01

3.  Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.

Authors:  J K Martin; M J O'Connell; H S Wieand; R J Fitzgibbons; J A Mailliard; J Rubin; D M Nagorney; L K Tschetter; J E Krook
Journal:  Arch Surg       Date:  1990-08

4.  Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases.

Authors:  D Burke; S Earlam; C Fordy; T G Allen-Mersh
Journal:  Br J Surg       Date:  1995-08       Impact factor: 6.939

Review 5.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

6.  Regional hepatic chemotherapy using an implantable drug infusion pump.

Authors:  A M Cohen; S D Kaufman; W C Wood; A J Greenfield
Journal:  Am J Surg       Date:  1983-04       Impact factor: 2.565

7.  Importance of hepatic artery node involvement in patients with colorectal liver metastases.

Authors:  M J Dworkin; S Earlam; C Fordy; T G Allen-Mersh
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

8.  Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis.

Authors:  T Ueda; E Shimada; T Urakawa
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

9.  Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

Authors:  P Piedbois; M Buyse; N Kemeny; P Rougier; R Carlson; T Allen-Mersh; M O'Connell; A Chang; V Sondak; M Kemeny; E Levy
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

10.  Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

Authors:  T G Allen-Mersh; S Earlam; C Fordy; K Abrams; J Houghton
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321
View more
  2 in total

1.  Relation between depression and circulating immune products in patients with advanced colorectal cancer.

Authors:  T G Allen-Mersh; C Glover; C Fordy; D C Henderson; M Davies
Journal:  J R Soc Med       Date:  1998-08       Impact factor: 5.344

2.  Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.

Authors:  C Fordy; C Glover; M M Davies; T G Allen-Mersh
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.